J. Emory Parker

3 weeks ago | statnews.com | Lizzy Lawrence |J. Emory Parker

WASHINGTON — The Food and Drug Administration always looks a little different after an administration change. Political appointees are swapped out, maybe some offices are restructured. But the FDA under the new Trump administration is already starting to look dramatically different. It’s hard to keep track of how many people have left, with departures stemming from early retirements, layoffs, buyout offers, or even forced resignations.

1 month ago | statnews.com | Elaine Chen |J. Emory Parker

Pfizer on Thursday made significant changes to its diversity, equity, and inclusion webpage, as companies across different industries seek to reposition their policies and messaging amid President Trump’s dismantling of DEI initiatives. The pharma company now emphasizes merit throughout its webpage.

Sep 3, 2024 | statnews.com | J. Emory Parker |Katie M. Palmer

Every day, physicians use clinical algorithms to make decisions about the patients in their exam rooms. To help weigh a patient’s surgical risk or likelihood of disease, they factor in attributes such as blood pressure, age, weight, surgical history — and in some cases, a patient’s race.

Jul 18, 2024 | statnews.com | Elizabeth Cooney |Andrew Joseph |Rohan Rajeev |J. Emory Parker

President Biden’s positive test for Covid-19 on Wednesday is a sign of a broader trend: Covid cases are on the rise this summer, gauged by rising wastewater measures and an increase in hospitalizations. Many Americans have likely experienced the uptick firsthand over the past few weeks. They’ve either tested positive themselves or know someone else chagrined to see those two lines bloom on a home test.

Jul 5, 2024 | statnews.com | Nicholas Florko |J. Emory Parker

WASHINGTON — Pharmaceutical giant AbbVie paid health care providers roughly $145.7 million last year to promote its drugs, according to a STAT analysis of newly released government data. The massive sum spent by AbbVie, the maker of the mega blockbuster anti-inflammatory drug Humira, is the most a pharmaceutical company has spent on marketing to doctors since such data became available in 2017.